28 फ़रवरी 2027
FDA PDUFA target action date for AD109 (aroxybutynin and atomoxetine), a NDA from Apnimed. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA निर्णय तारीखें कैलेंडर